Fulgent Genetics Inc [FLGT] stock is trading at $30.65, up 2.17%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The FLGT shares have gain 6.39% over the last week, with a monthly amount glided 29.11%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Fulgent Genetics Inc [NASDAQ: FLGT] stock has seen the most recent analyst activity on August 05, 2025, when UBS upgraded its rating to a Buy but kept the price target unchanged to $30 for it. Previously, UBS started tracking the stock with Neutral rating on December 07, 2023, and set its price target to $35. On December 08, 2022, downgrade downgraded it’s rating to Neutral and revised its price target to $40 on the stock. Raymond James started tracking the stock assigning an Outperform rating and suggested a price target of $45 on November 18, 2022. Credit Suisse initiated its recommendation with an Outperform and recommended $65 as its price target on August 25, 2022.
Fulgent Genetics Inc [FLGT] stock has fluctuated between $14.57 and $30.59 over the past year. Currently, Wall Street analysts expect the stock to reach $29 within the next 12 months. Fulgent Genetics Inc [NASDAQ: FLGT] shares were valued at $30.65 at the most recent close of the market. An investor can expect a potential drop of -5.38% based on the average FLGT price forecast.
Analyzing the FLGT fundamentals
Fulgent Genetics Inc [NASDAQ:FLGT] reported sales of 315.55M for the trailing twelve months, which represents a growth of 17.18%. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.15%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.04 and Total Capital is -0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.91 points at the first support level, and at 29.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 31.03, and for the 2nd resistance point, it is at 31.41.
Ratios To Look Out For
For context, Fulgent Genetics Inc’s Current Ratio is 7.01. As well, the Quick Ratio is 7.01, while the Cash Ratio is 1.62. Considering the valuation of this stock, the price to sales ratio is 3.00, the price to book ratio is 0.84.
Transactions by insiders
Recent insider trading involved Xie Jian, Officer, that happened on Nov 24 ’25 when 681.0 shares were purchased. Officer, Gao Hanlin completed a deal on Nov 24 ’25 to buy 535.0 shares. Meanwhile, President and COO Xie Jian sold 10000.0 shares on Nov 19 ’25.
